Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co IncfiledCriticalMerck and Co Inc
Publication of ES409205A1publicationCriticalpatent/ES409205A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A process for the preparation of a 1,2alpha-methylene-6,7alpha-dihalomethylene-20-spirox-4-ene 3-oxygenate, which consists in treating a 1,2alpha-methylene-6,7alpha-dihalomethylene-17alpha- ( 3-hydroxypropyl) -17beta-hydroxyandrost-4-en-3-one with an agent capable of closing the ring. (Machine-translation by Google Translate, not legally binding)
ES409205A1970-03-191972-12-01
A PROCEDURE FOR THE PREPARATION OF A 1,2 ALPHA-METHYLEN-6,7 ALPHA-DIHALOMETILEN-20-SPIROX-4-ENO 3-OXYGENADO.
ExpiredES409205A1
(en)
Procedure for the preparation of 3-hydroxy-7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiacepin-2-ona. (Machine-translation by Google Translate, not legally binding)